mohammad rashidian - Search Results

Year	Number of Results
2008	1
2009	1
2010	2
2012	1
2013	4
2015	5
2016	1
2017	4
2018	3
2019	2
2020	5
2021	8
2022	6
2023	1

1

Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition.

Priem B, van Leent MMT, Teunissen AJP, Sofias AM, Mourits VP, Willemsen L, Klein ED, Oosterwijk RS, Meerwaldt AE, Munitz J, Prévot G, Vera Verschuur A, Nauta SA, van Leeuwen EM, Fisher EL, de Jong KAM, Zhao Y, Toner YC, Soultanidis G, Calcagno C, Bomans PHH, Friedrich H, Sommerdijk N, Reiner T, Duivenvoorden R, Zupančič E, Di Martino JS, Kluza E, Rashidian M, Ploegh HL, Dijkhuizen RM, Hak S, Pérez-Medina C, Bravo-Cordero JJ, de Winther MPJ, Joosten LAB, van Elsas A, Fayad ZA, Rialdi A, Torre D, Guccione E, Ochando J, Netea MG, Griffioen AW, Mulder WJM. Priem B, et al. Among authors: rashidian m. Cell. 2020 Oct 29;183(3):786-801.e19. doi: 10.1016/j.cell.2020.09.059. Cell. 2020. PMID: 33125893 Free PMC article.

2

Direct and Indirect Regulators of Epithelial-Mesenchymal Transition-Mediated Immunosuppression in Breast Carcinomas.

Dongre A, Rashidian M, Eaton EN, Reinhardt F, Thiru P, Zagorulya M, Nepal S, Banaz T, Martner A, Spranger S, Weinberg RA. Dongre A, et al. Among authors: rashidian m. Cancer Discov. 2021 May;11(5):1286-1305. doi: 10.1158/2159-8290.CD-20-0603. Epub 2020 Dec 16. Cancer Discov. 2021. PMID: 33328216 Free PMC article.

3

Employing nanobodies for immune landscape profiling by PET imaging in mice.

Teunissen AJP, Abousaway OB, Munitz J, van Leent MMT, Toner YC, Priem B, Senders ML, Pérez-Medina C, Mulder WJM, Rashidian M. Teunissen AJP, et al. Among authors: rashidian m. STAR Protoc. 2021 Apr 5;2(2):100434. doi: 10.1016/j.xpro.2021.100434. eCollection 2021 Jun 18. STAR Protoc. 2021. PMID: 33899016 Free PMC article.

4

Noninvasive Imaging of Cancer Immunotherapy.

Abousaway O, Rakhshandehroo T, Van den Abbeele AD, Kircher MF, Rashidian M. Abousaway O, et al. Among authors: rashidian m. Nanotheranostics. 2021 Jan 1;5(1):90-112. doi: 10.7150/ntno.50860. eCollection 2021. Nanotheranostics. 2021. PMID: 33391977 Free PMC article. Review.

5

Molecular Immune Targeted Imaging of Tumor Microenvironment.

Rakhshandehroo T, Smith BR, Glockner HJ, Rashidian M, Pandit-Taskar N. Rakhshandehroo T, et al. Among authors: rashidian m. Nanotheranostics. 2022 Feb 15;6(3):286-305. doi: 10.7150/ntno.66556. eCollection 2022. Nanotheranostics. 2022. PMID: 35223381 Free PMC article. Review.

6

Probing immune infiltration dynamics in cancer by in vivo imaging.

Ng TSC, Allen HH, Rashidian M, Miller MA. Ng TSC, et al. Among authors: rashidian m. Curr Opin Chem Biol. 2022 Apr;67:102117. doi: 10.1016/j.cbpa.2022.102117. Epub 2022 Feb 23. Curr Opin Chem Biol. 2022. PMID: 35219177 Review.

7

Design and synthesis of gold nanostars-based SERS nanotags for bioimaging applications.

Andreiuk B, Nicolson F, Clark LM, Panikkanvalappil SR, Kenry, Rashidian M, Harmsen S, Kircher MF. Andreiuk B, et al. Among authors: rashidian m. Nanotheranostics. 2022 Jan 1;6(1):10-30. doi: 10.7150/ntno.61244. eCollection 2022. Nanotheranostics. 2022. PMID: 34976578 Free PMC article. Review.

8

Nanobodies for Medical Imaging: About Ready for Prime Time?

Berland L, Kim L, Abousaway O, Mines A, Mishra S, Clark L, Hofman P, Rashidian M. Berland L, et al. Among authors: rashidian m. Biomolecules. 2021 Apr 26;11(5):637. doi: 10.3390/biom11050637. Biomolecules. 2021. PMID: 33925941 Free PMC article. Review.

9

Enzymatic labeling of proteins: techniques and approaches.

Rashidian M, Dozier JK, Distefano MD. Rashidian M, et al. Bioconjug Chem. 2013 Aug 21;24(8):1277-94. doi: 10.1021/bc400102w. Bioconjug Chem. 2013. PMID: 23837885 Free PMC article. Review.

10

Direct N- or C-Terminal Protein Labeling Via a Sortase-Mediated Swapping Approach.

Cong M, Tavakolpour S, Berland L, Glöckner H, Andreiuk B, Rakhshandehroo T, Uslu S, Mishra S, Clark L, Rashidian M. Cong M, et al. Among authors: rashidian m. Bioconjug Chem. 2021 Nov 17;32(11):2397-2406. doi: 10.1021/acs.bioconjchem.1c00442. Epub 2021 Nov 8. Bioconjug Chem. 2021. PMID: 34748323 Free PMC article.

11

Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses.

Woodham AW, Cheloha RW, Ling J, Rashidian M, Kolifrath SC, Mesyngier M, Duarte JN, Bader JM, Skeate JG, Da Silva DM, Kast WM, Ploegh HL. Woodham AW, et al. Among authors: rashidian m. Cancer Immunol Res. 2018 Jul;6(7):870-880. doi: 10.1158/2326-6066.CIR-17-0661. Epub 2018 May 23. Cancer Immunol Res. 2018. PMID: 29792298 Free PMC article.

12

Noninvasive imaging of immune responses.

Rashidian M, Keliher EJ, Bilate AM, Duarte JN, Wojtkiewicz GR, Jacobsen JT, Cragnolini J, Swee LK, Victora GD, Weissleder R, Ploegh HL. Rashidian M, et al. Proc Natl Acad Sci U S A. 2015 May 12;112(19):6146-51. doi: 10.1073/pnas.1502609112. Epub 2015 Apr 20. Proc Natl Acad Sci U S A. 2015. PMID: 25902531 Free PMC article.

13

Lymphopenia during the COVID-19 infection: What it shows and what can be learned.

Tavakolpour S, Rakhshandehroo T, Wei EX, Rashidian M. Tavakolpour S, et al. Among authors: rashidian m. Immunol Lett. 2020 Sep;225:31-32. doi: 10.1016/j.imlet.2020.06.013. Epub 2020 Jun 20. Immunol Lett. 2020. PMID: 32569607 Free PMC article. No abstract available.

14

HIV-infected macrophages resist efficient NK cell-mediated killing while preserving inflammatory cytokine responses.

Clayton KL, Mylvaganam G, Villasmil-Ocando A, Stuart H, Maus MV, Rashidian M, Ploegh HL, Walker BD. Clayton KL, et al. Among authors: rashidian m. Cell Host Microbe. 2021 Mar 10;29(3):435-447.e9. doi: 10.1016/j.chom.2021.01.006. Epub 2021 Feb 10. Cell Host Microbe. 2021. PMID: 33571449 Free PMC article.

15

Anti-CTLA-4 therapy requires an Fc domain for efficacy.

Ingram JR, Blomberg OS, Rashidian M, Ali L, Garforth S, Fedorov E, Fedorov AA, Bonanno JB, Le Gall C, Crowley S, Espinosa C, Biary T, Keliher EJ, Weissleder R, Almo SC, Dougan SK, Ploegh HL, Dougan M. Ingram JR, et al. Among authors: rashidian m. Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):3912-3917. doi: 10.1073/pnas.1801524115. Epub 2018 Mar 26. Proc Natl Acad Sci U S A. 2018. PMID: 29581255 Free PMC article.

16

PD-L1 is an activation-independent marker of brown adipocytes.

Ingram JR, Dougan M, Rashidian M, Knoll M, Keliher EJ, Garrett S, Garforth S, Blomberg OS, Espinosa C, Bhan A, Almo SC, Weissleder R, Lodish H, Dougan SK, Ploegh HL. Ingram JR, et al. Among authors: rashidian m. Nat Commun. 2017 Sep 21;8(1):647. doi: 10.1038/s41467-017-00799-8. Nat Commun. 2017. PMID: 28935898 Free PMC article.

17

Enzymatic Construction of DARPin-Based Targeted Delivery Systems Using Protein Farnesyltransferase and a Capture and Release Strategy.

Zhang Y, Wang Y, Uslu S, Venkatachalapathy S, Rashidian M, Schaefer JV, Plückthun A, Distefano MD. Zhang Y, et al. Among authors: rashidian m. Int J Mol Sci. 2022 Sep 29;23(19):11537. doi: 10.3390/ijms231911537. Int J Mol Sci. 2022. PMID: 36232839 Free PMC article.

18

Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas.

Dongre A, Rashidian M, Reinhardt F, Bagnato A, Keckesova Z, Ploegh HL, Weinberg RA. Dongre A, et al. Among authors: rashidian m. Cancer Res. 2017 Aug 1;77(15):3982-3989. doi: 10.1158/0008-5472.CAN-16-3292. Epub 2017 Apr 20. Cancer Res. 2017. PMID: 28428275 Free PMC article.

19

Pustular eruption after biosimilar rituximab infusion: report of acute generalized exanthematous pustulosis in two patients with pemphigus.

Daneshpazhooh M, Tavakolpour S, Salehi Farid A, Ebadi M, Nili A, Rashidian M, Mahmoudi H. Daneshpazhooh M, et al. Among authors: rashidian m. Int J Dermatol. 2022 Jan;61(1):e14-e17. doi: 10.1111/ijd.15706. Epub 2021 Jun 22. Int J Dermatol. 2022. PMID: 34156705 No abstract available.

20

Treatment of pemphigus patients in the COVID-19 era: A specific focus on rituximab.

Mahmoudi H, Tavakolpour S, Nili A, Salehi Farid A, Daneshpazhooh M, Rashidian M. Mahmoudi H, et al. Among authors: rashidian m. Dermatol Ther. 2020 Nov;33(6):e14188. doi: 10.1111/dth.14188. Epub 2020 Sep 3. Dermatol Ther. 2020. PMID: 32794333 Free PMC article. No abstract available.

21

In vivo detection of antigen-specific CD8⁺ T cells by immuno-positron emission tomography.

Woodham AW, Zeigler SH, Zeyang EL, Kolifrath SC, Cheloha RW, Rashidian M, Chaparro RJ, Seidel RD, Garforth SJ, Dearling JL, Mesyngier M, Duddempudi PK, Packard AB, Almo SC, Ploegh HL. Woodham AW, et al. Among authors: rashidian m. Nat Methods. 2020 Oct;17(10):1025-1032. doi: 10.1038/s41592-020-0934-5. Epub 2020 Sep 14. Nat Methods. 2020. PMID: 32929269 Free PMC article.

22

Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1-Specific VHHs.

Dougan M, Ingram JR, Jeong HJ, Mosaheb MM, Bruck PT, Ali L, Pishesha N, Blomberg O, Tyler PM, Servos MM, Rashidian M, Nguyen QD, von Andrian UH, Ploegh HL, Dougan SK. Dougan M, et al. Among authors: rashidian m. Cancer Immunol Res. 2018 Apr;6(4):389-401. doi: 10.1158/2326-6066.CIR-17-0495. Epub 2018 Feb 19. Cancer Immunol Res. 2018. PMID: 29459478 Free PMC article.

23

Converting an Anti-Mouse CD4 Monoclonal Antibody into an scFv Positron Emission Tomography Imaging Agent for Longitudinal Monitoring of CD4⁺ T Cells.

Islam A, Pishesha N, Harmand TJ, Heston H, Woodham AW, Cheloha RW, Bousbaine D, Rashidian M, Ploegh HL. Islam A, et al. Among authors: rashidian m. J Immunol. 2021 Sep 1;207(5):1468-1477. doi: 10.4049/jimmunol.2100274. Epub 2021 Aug 18. J Immunol. 2021. PMID: 34408009 Free PMC article.

24

Simultaneous Site-Specific Dual Protein Labeling Using Protein Prenyltransferases.

Zhang Y, Blanden MJ, Sudheer Ch, Gangopadhyay SA, Rashidian M, Hougland JL, Distefano MD. Zhang Y, et al. Among authors: rashidian m. Bioconjug Chem. 2015 Dec 16;26(12):2542-53. doi: 10.1021/acs.bioconjchem.5b00553. Epub 2015 Dec 4. Bioconjug Chem. 2015. PMID: 26561785 Free PMC article.

25

Enhanced Tumor Accumulation of Multimodal Magneto-Plasmonic Nanoparticles via an Implanted Micromagnet-Assisted Delivery Strategy.

Panikkanvalappil SR, Bhagavatula SK, Deans K, Jonas O, Rashidian M, Mishra S. Panikkanvalappil SR, et al. Among authors: rashidian m. Adv Healthc Mater. 2023 Jan;12(2):e2201585. doi: 10.1002/adhm.202201585. Epub 2022 Oct 26. Adv Healthc Mater. 2023. PMID: 36213946

26

Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix.

Jailkhani N, Ingram JR, Rashidian M, Rickelt S, Tian C, Mak H, Jiang Z, Ploegh HL, Hynes RO. Jailkhani N, et al. Among authors: rashidian m. Proc Natl Acad Sci U S A. 2019 Jul 9;116(28):14181-14190. doi: 10.1073/pnas.1817442116. Epub 2019 May 8. Proc Natl Acad Sci U S A. 2019. PMID: 31068469 Free PMC article.

27

Enzyme-Mediated Modification of Single-Domain Antibodies for Imaging Modalities with Different Characteristics.

Rashidian M, Wang L, Edens JG, Jacobsen JT, Hossain I, Wang Q, Victora GD, Vasdev N, Ploegh H, Liang SH. Rashidian M, et al. Angew Chem Int Ed Engl. 2016 Jan 11;55(2):528-533. doi: 10.1002/anie.201507596. Epub 2015 Dec 2. Angew Chem Int Ed Engl. 2016. PMID: 26630549 Free PMC article.

28

Simultaneous dual protein labeling using a triorthogonal reagent.

Rashidian M, Kumarapperuma SC, Gabrielse K, Fegan A, Wagner CR, Distefano MD. Rashidian M, et al. J Am Chem Soc. 2013 Nov 6;135(44):16388-96. doi: 10.1021/ja403813b. Epub 2013 Oct 17. J Am Chem Soc. 2013. PMID: 24134212 Free PMC article.

29

Comparison of thermochemistry of aspartame (artificial sweetener) and glucose.

Rashidian M, Fattahi A. Rashidian M, et al. Carbohydr Res. 2009 Jan 5;344(1):127-33. doi: 10.1016/j.carres.2008.09.020. Epub 2008 Sep 26. Carbohydr Res. 2009. PMID: 18992876

30

The use of ¹⁸F-2-fluorodeoxyglucose (FDG) to label antibody fragments for immuno-PET of pancreatic cancer.

Rashidian M, Keliher E, Dougan M, Juras PK, Cavallari M, Wojtkiewicz GR, Jacobsen J, Edens JG, Tas JM, Victora G, Weissleder R, Ploegh H. Rashidian M, et al. ACS Cent Sci. 2015 Jun 24;1(3):142-147. doi: 10.1021/acscentsci.5b00121. Epub 2015 Jun 3. ACS Cent Sci. 2015. PMID: 26955657 Free PMC article.

31

Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease.

Van Elssen CHMJ, Rashidian M, Vrbanac V, Wucherpfennig KW, Habre ZE, Sticht J, Freund C, Jacobsen JT, Cragnolini J, Ingram J, Plaisier L, Spierings E, Tager AM, Ploegh HL. Van Elssen CHMJ, et al. Among authors: rashidian m. J Nucl Med. 2017 Jun;58(6):1003-1008. doi: 10.2967/jnumed.116.186007. Epub 2017 Feb 16. J Nucl Med. 2017. PMID: 28209904 Free PMC article.

32

Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells.

Rashidian M, Ingram JR, Dougan M, Dongre A, Whang KA, LeGall C, Cragnolini JJ, Bierie B, Gostissa M, Gorman J, Grotenbreg GM, Bhan A, Weinberg RA, Ploegh HL. Rashidian M, et al. J Exp Med. 2017 Aug 7;214(8):2243-2255. doi: 10.1084/jem.20161950. Epub 2017 Jun 30. J Exp Med. 2017. PMID: 28666979 Free PMC article.

33

Evaluation of alkyne-modified isoprenoids as chemical reporters of protein prenylation.

DeGraw AJ, Palsuledesai C, Ochocki JD, Dozier JK, Lenevich S, Rashidian M, Distefano MD. DeGraw AJ, et al. Among authors: rashidian m. Chem Biol Drug Des. 2010 Dec;76(6):460-71. doi: 10.1111/j.1747-0285.2010.01037.x. Epub 2010 Oct 11. Chem Biol Drug Des. 2010. PMID: 21040496 Free PMC article.

34

Chemoenzymatic reversible immobilization and labeling of proteins without prior purification.

Rashidian M, Song JM, Pricer RE, Distefano MD. Rashidian M, et al. J Am Chem Soc. 2012 May 23;134(20):8455-67. doi: 10.1021/ja211308s. Epub 2012 May 8. J Am Chem Soc. 2012. PMID: 22435540 Free PMC article.

35

A highly efficient catalyst for oxime ligation and hydrazone-oxime exchange suitable for bioconjugation.

Rashidian M, Mahmoodi MM, Shah R, Dozier JK, Wagner CR, Distefano MD. Rashidian M, et al. Bioconjug Chem. 2013 Mar 20;24(3):333-42. doi: 10.1021/bc3004167. Epub 2013 Mar 6. Bioconjug Chem. 2013. PMID: 23425124 Free PMC article.

36

Application of meta- and para-Phenylenediamine as Enhanced Oxime Ligation Catalysts for Protein Labeling, PEGylation, Immobilization, and Release.

Mahmoodi MM, Rashidian M, Zhang Y, Distefano MD. Mahmoodi MM, et al. Among authors: rashidian m. Curr Protoc Protein Sci. 2015 Feb 2;79:15.4.1-15.4.28. doi: 10.1002/0471140864.ps1504s79. Curr Protoc Protein Sci. 2015. PMID: 25640893 Free PMC article.

37

Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade.

Rashidian M, LaFleur MW, Verschoor VL, Dongre A, Zhang Y, Nguyen TH, Kolifrath S, Aref AR, Lau CJ, Paweletz CP, Bu X, Freeman GJ, Barrasa MI, Weinberg RA, Sharpe AH, Ploegh HL. Rashidian M, et al. Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):16971-16980. doi: 10.1073/pnas.1905005116. Epub 2019 Aug 2. Proc Natl Acad Sci U S A. 2019. PMID: 31375632 Free PMC article.

38

Chemoenzymatic site-specific reversible immobilization and labeling of proteins from crude cellular extract without prior purification using oxime and hydrazine ligation.

Mahmoodi MM, Rashidian M, Dozier JK, Distefano MD. Mahmoodi MM, et al. Among authors: rashidian m. Curr Protoc Chem Biol. 2013;5(2):89-109. doi: 10.1002/9780470559277.ch120247. Curr Protoc Chem Biol. 2013. PMID: 23839992 Free PMC article.

39

Selective labeling of polypeptides using protein farnesyltransferase via rapid oxime ligation.

Rashidian M, Dozier JK, Lenevich S, Distefano MD. Rashidian M, et al. Chem Commun (Camb). 2010 Dec 21;46(47):8998-9000. doi: 10.1039/c0cc03305g. Epub 2010 Oct 22. Chem Commun (Camb). 2010. PMID: 20967387 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results